FDA Investigator Victoria M Daddeo

Victoria M Daddeo has conducted inspections on 66 sites in 3 countries as of 16 Nov 2021. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
66
Last Inspection Date:
16 Nov 2021
Investigator Role:
FDA Investigator
Redica ID:
100008317
Countries of Inspections:
United States of America, Austria, India
FDA Investigators that have inspected at least one site in common with Victoria M Daddeo:
Aisha P Johnson, Alan R Condon, Alicia A Dalley, Amber G Wardwell, Amy C Jordan, Andrew R Wasko, Anna M Brannen, Anthony C Warchut, Anthony N Onianwa, Barbara D Wright, Betsy C Galliher, Byungja E Marciante, Christine M Whitby, CSO, Christopher Janik, Chunsheng Cai, PhD, Constance Desimone, Courtney N Long, Cynthia F Kleppinger, MD, Darin S Wiegers, Daryl A Dewoskin, David P Vanhouten, Deborah A Greco, Deborah M Trout, Diane C Thibodeau, Diane M Prince, Dien N Nguyen, Douglas Fiorentino Lcdr, Dr. Abhijit Raha, PhD, Dr. Zhou Chen (nmi), MD PhD, Edmund F Mrak, Jr, Edward J Janik, Gabrielle J Swain, Geoffrey K Kilili, Hang N Guo, Harlan J Howard, Jamie S Mathews, Janete F Guardia, Jennifer C Adams, John J Thibodeau, John L Zaccone, John P Mistler, John S Hartford, Jonah S Ufferfilge, Jose A Torres, Justine M Corson, Kathryn Suttling, Kenneth H Williams, Kent A Conforti, Laurel A Beer, Lauren Iacono Connors, PhD, Laurie B Frazier, LCDR Debra Emerson, Leo B Zadecky, Lucie Yang, Marcia A Worley, Margaret E Walsh, Margaret M Sands, Mark R Mcclain, Martin J Guardia, Mary Jeanet Mcgarry, Matthew C Watson, Maya M Davis, Megan A Haggerty, Meredith L Miller, Miah Jung, Michael P Anthony, Michael Serrano, Michelle M Noe Varga, Michelle Rfrazier Jessen, PhD, Monique C Lo, Nabil Nakhoul, Nealie C Newberger, Nicole M Li, Nina Yang, Paraluman S Leonin, Paul Lihong Yeh, PhD, Peter R Lenahan, Philip Kreiter, Phillip D Kronstein, MD, Rapti D Madurawe, Richard W Berning, Robert J Martin, Robert O'brian, Sandra P White, Sharon K Gershon, Sherri N Rohlf, MD, Simone E Pitts, Stacey S Degarmo, Stephanie Mangigian, MS/OSH, RN, Stephen R Souza, Susanne M Richardson, MS RAC, Suzanne M Healy, Tracey L Harris, Victor J Gangi, Victoria D'addeo, Yvette Mlacour Davis

Victoria M Daddeo's Documents

Publish Date Document Type Title
October, 2021 FDA 483 Andrea J. Bullock, MD - Form 483, 2021-10-06
April, 2018 FDA 483 Response Alnylam Pharmaceuticals, Inc. - Form 483R, 2018-05-11
April, 2019 FDA 483 Memorial Hospital of Rhode Island IRB - Form 483, 2019-04-17
June, 2018 FDA 483 Pfizer Laboratories Div Pfizer Inc - Form 483, 2018-06-21
February, 2019 FDA 483 Brian J Byrne, MD - Form 483, 2019-02-22
June, 2018 EIR Pfizer Laboratories Div Pfizer Inc - EIR, 2018-06-21
March, 2021 FDA 483 Andrew J. Wagner, M.D. - Form 483, 2021-03-04
November, 2016 FDA 483 Radius Health, Inc. - Form 483, 2016-11-14
April, 2018 EIR Medpace Inc - EIR, 2018-04-20
December, 2018 FDA 483 Boehringer Ingelheim Pharmaceuticals, Inc. - Form 483, 2018-12-06
July, 2019 EIR Perceptive Informatics LLC (d.b.a. Calyx) - EIR, 2019-07-15
January, 2017 FDA 483 Women & Infants Hospital IRB - Form 483, 2017-01-11
May, 2017 FDA 483 ARIAD Pharmaceuticals - Form 483, 2017-05-31
April, 2018 FDA 483 Medpace Inc - Form 483, 2018-04-20
April, 2018 EIR Alnylam Pharmaceuticals, Inc. - EIR, 2018-04-25
January, 2020 FDA 483 Benjamin Nwosu MD - Form 483, 2020-01-08

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more